Countdown to Cigna (CI) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Werte in diesem Artikel
In its upcoming report, Cigna (CI) is predicted by Wall Street analysts to post quarterly earnings of $7.22 per share, reflecting an increase of 6.7% compared to the same period last year. Revenues are forecasted to be $59.84 billion, representing a year-over-year increase of 21.9%.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.Given this perspective, it's time to examine the average forecasts of specific Cigna metrics that are routinely monitored and predicted by Wall Street analysts.According to the collective judgment of analysts, 'Revenues- Net investment income' should come in at $293.78 million. The estimate indicates a change of -8.5% from the prior-year quarter.It is projected by analysts that the 'Revenues- Premiums' will reach $11.40 billion. The estimate indicates a change of +3.7% from the prior-year quarter.The average prediction of analysts places 'Revenues- Evernorth Health Services' at $48.96 billion. The estimate indicates a change of +26.9% from the prior-year quarter.The combined assessment of analysts suggests that 'Revenues- Pharmacy' will likely reach $44.47 billion. The estimate suggests a change of +28.8% year over year.Analysts' assessment points toward 'Revenues- Fees and Other' reaching $3.50 billion. The estimate indicates a change of +9.5% from the prior-year quarter.The consensus among analysts is that 'Revenues- Cigna Healthcare- Premiums' will reach $11.27 billion. The estimate suggests a change of +3.3% year over year.Based on the collective assessment of analysts, 'Revenues- Cigna Healthcare- Premiums- U.S. Commercial - Total' should arrive at $9.66 billion. The estimate indicates a change of +59.6% from the prior-year quarter.Analysts forecast 'Medical Care Ratio - Cigna Healthcare' to reach 83.0%. Compared to the present estimate, the company reported 80.5% in the same quarter last year.Analysts predict that the 'Medical Customers - Total' will reach 19,173.91 thousand. The estimate compares to the year-ago value of 19.61 million.Analysts expect 'Medical Customers - International Health administrative services' to come in at 428.33 thousand. Compared to the current estimate, the company reported 430 thousand in the same quarter of the previous year.The collective assessment of analysts points to an estimated 'Covered Lives By Funding Type - Medical Customers - International Health insured' of 1,216.82 thousand. Compared to the current estimate, the company reported 1.2 million in the same quarter of the previous year.The consensus estimate for 'Medical Customers - U.S. Healthcare administrative services' stands at 13,646.40 thousand. The estimate compares to the year-ago value of 13.79 million.View all Key Company Metrics for Cigna here>>>Over the past month, Cigna shares have recorded returns of -8.9% versus the Zacks S&P 500 composite's +2% change. Based on its Zacks Rank #4 (Sell), CI will likely underperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cigna Group (CI): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf The Cigna Group Registered
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf The Cigna Group Registered
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu The Cigna Group Registered Shs
Analysen zu The Cigna Group Registered Shs
Datum | Rating | Analyst | |
---|---|---|---|
20.07.2018 | Express Scripts Neutral | Robert W. Baird & Co. Incorporated | |
08.03.2018 | Express Scripts Equal Weight | Barclays Capital | |
08.03.2018 | Cigna Overweight | Barclays Capital | |
31.01.2018 | Express Scripts Outperform | RBC Capital Markets | |
15.12.2017 | Express Scripts Outperform | Robert W. Baird & Co. Incorporated |
Datum | Rating | Analyst | |
---|---|---|---|
08.03.2018 | Cigna Overweight | Barclays Capital | |
31.01.2018 | Express Scripts Outperform | RBC Capital Markets | |
15.12.2017 | Express Scripts Outperform | Robert W. Baird & Co. Incorporated | |
14.12.2017 | Express Scripts Buy | Maxim Group | |
04.12.2017 | Express Scripts Buy | Deutsche Bank AG |
Datum | Rating | Analyst | |
---|---|---|---|
20.07.2018 | Express Scripts Neutral | Robert W. Baird & Co. Incorporated | |
08.03.2018 | Express Scripts Equal Weight | Barclays Capital | |
19.09.2017 | Express Scripts Sector Perform | RBC Capital Markets | |
21.07.2017 | Express Scripts Hold | Needham & Company, LLC | |
26.04.2017 | Express Scripts Hold | Edward Jones |
Datum | Rating | Analyst | |
---|---|---|---|
22.02.2016 | Express Scripts Sell | Deutsche Bank AG | |
13.01.2009 | CIGNA sell | Citigroup Corp. | |
07.11.2007 | CIGNA underweight | Lehman Brothers Inc. | |
02.11.2006 | Update CIGNA Corp.: Underweight | Lehman Brothers |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für The Cigna Group Registered Shs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen